In another study on “eraser” ALKBH5, researchers found that the knockout of ALKBH5 in mice with CT26 colorectal cancer or B16 melanoma significantly reduced tumor growth and prolonged the survival rate of mice during immunotherapy. This evidence concerns the gene ALKBH5 and neoplasm.